Developer docs
API playgroundTry for free, no card

Search company profiles

Actor Pharmaceuticals Pty Ltd

Full company profile

uuid003ryq5

Namestring
Actor Pharmaceuticals Pty Ltd
Legal namestring
Actor Pharmaceuticals Pty Ltd
Company typeenum
Private
Founded yearstring
-
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmaceuticals, over-the-counter medicines, prescription medications, consumer health products, biosimilar medicines
Industry2 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Health and Personal Care Retailers456
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Specialty Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Prescription Pharmaceuticals
TypeOne Time License
Description

Sale of prescription specialty pharmaceuticals and biosimilar medicines to healthcare professionals and patients in Australia, with some products listed on the Pharmaceutical Benefits Scheme (PBS).

actorpharma.com.au
2Over-the-Counter (OTC) Consumer Health Products
TypeOne Time License
Description

Sale of OTC consumer health products directly to consumers through their e-commerce platform and through pharmacy distribution channels.

actorpharma.com.au
3Licensing Royalties
TypeLicensing Royalties
Description

Klisyri is a registered trademark under license by Almirall, S.A., indicating a licensing arrangement for certain products.

actorpharma.com.au
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Over-the-counter consumer health products sold via e-commerce
ModelUnit PricingBilling cadencePay-as-you-go
Notes

OTC products available for purchase through the company website with product-specific pricing.

actorpharma.com.au
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 12 records shown
1Prospan
Description

Scientifically researched to relieve chesty cough, clear the airways and soothe the throat

actorpharma.com.au
+11 more records
Core offering1 text field

Actor Pharmaceuticals Pty Ltd distributes and markets a portfolio of prescription specialty pharmaceuticals and biosimilar medicines alongside a 12-brand range of over-the-counter consumer health products covering anxiety/mood, antifungal, cough/cold, digestive, pain management, skincare, sleep, and women's wellness. The company serves Australian consumers directly through its Shopify-based e-commerce platform and Australian pharmacies, with select brands (e.g., Prospan) also distributed in New Zealand via local partners.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Actor Pharmaceuticals Pty Ltd is an Australian specialty pharmaceutical company offering a dual portfolio of Consumer Health (OTC) products and Prescription Medicines. The Consumer Health portfolio includes 12 over-the-counter brands covering therapeutic categories including Sinupret® (sinusitis), Premular®/Femular®/Redormin®/Remotiv® (women's wellness and sleep/anxiety), Kenkay®/DermaScar® (skincare), Zostrix® (pain relief), Prospan® (cough), Excilor (antifungal), Canephron® (urinary health), and Prunelax® (digestive). The Prescription Medicines division provides specialist treatments including ACTOBET® and WYNZORA® (dermatology, calcipotriol/betamethasone), ANDRIGA-10® (urology/oncology), AXHIDROX® (hyperhidrosis), and KLISYRI® (actinic keratosis). The company also distributes biosimilar medicines to the Australian healthcare industry.

Product and service1 record
1Prospan
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Klisyri (tirbanibulin ointment) is a registered trademark under license by Almirall, S.A., indicating a licensing arrangement where Actor Pharmaceuticals distributes this product in Australia.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Axhidrox (glycopyrronium bromide cream) is a registered trademark of Dr. August Wolff GmbH & Co. KG Arzneimittel, licensed to Actor Pharmaceuticals for distribution.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

WYNZORA (calcipotriol and betamethasone cream) is a registered trademark of MC2 Therapeutics Pty Ltd with PAD Technology trademark, licensed to Actor Pharmaceuticals for Australian distribution.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Privately held Australian specialty pharmaceutical and OTC consumer health company, with a comparable portfolio of dermatology (QV skincare) and prescription products marketed through Australian pharmacies — directly comparable in business model and target market.

TypeDirect peer
Description

Australian specialty and generic pharmaceutical company supplying PBS-listed medicines through pharmacy channels — direct comparable for Actor's prescription distribution and PBS strategy.

TypeDirect peer
Description

Australia/NZ-focused specialty pharma company selling prescription medicines and OTC consumer health brands through pharmacy and healthcare professional channels, closely mirroring Actor's Rx + OTC dual model.

TypeBroad incumbent
Description

ASX-listed Australian specialty pharmaceutical company focused on branded Rx and dermatology products, providing a scaled publicly-listed comparison for Actor's specialty prescription portfolio.

TypeBroad incumbent
Description

Specialty pharmaceutical group with deep Australian and Asia-Pacific presence in pain, oncology and consumer health — competing with Actor's prescription pain (Zostrix-equivalents) and OTC categories.

TypeBroad incumbent
Description

Multinational consumer health division with established Australian OTC portfolio across cough/cold, pain and dermatology — directly relevant peer for Actor's consumer health categories.

TypeBroad incumbent
Description

Multinational pharmaceutical company with a sizeable Australian consumer health and specialty Rx franchise, similar multi-channel mix at materially greater scale.

TypeBroad incumbent
Description

Australian arm of a global specialty and generic pharma group marketing a broad branded Rx and OTC portfolio through local distribution — overlaps with Actor's portfolio breadth but at far greater scale.

TypeBroad incumbent
Description

Leading Australian OTC consumer health brand company, competing head-on with Actor's OTC supplements for women's wellness, sleep and anxiety (e.g. Remotiv, Redormin).

TypeDirect peer
Description

ASX- and NZX-listed specialty pharma company commercialising patented and in-licensed prescription and OTC products across Australia and New Zealand, comparable in geographic focus and licensing-driven model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Actor Pharmaceuticals Pty Ltd

Specialty Pharmaceuticalsactorpharma.com.au

Actor Pharmaceuticals Pty Ltd firmographics

Firmographics
Name
Actor Pharmaceuticals Pty Ltd
Legal name
Actor Pharmaceuticals Pty Ltd
Website
https://actorpharma.com.au
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Actor Pharmaceuticals Pty Ltd industry classification

Industry
Product category
Specialty Pharmaceuticals
NAICS
Health and Personal Care Retailers (456)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Specialty pharmaceuticals
  • Over-the-counter medicines
  • Prescription medications
  • Consumer health products
  • Biosimilar medicines

Where Actor Pharmaceuticals Pty Ltd is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Actor Pharmaceuticals Pty Ltd business model

Business model
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Prescription Pharmaceuticals: Sale of prescription specialty pharmaceuticals and biosimilar medicines to healthcare professionals and patients in Australia, with some products listed on the Pharmaceutical Benefits Scheme (PBS).
  2. Over-the-Counter (OTC) Consumer Health Products: Sale of OTC consumer health products directly to consumers through their e-commerce platform and through pharmacy distribution channels.
  3. Licensing Royalties: Klisyri is a registered trademark under license by Almirall, S.A., indicating a licensing arrangement for certain products.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goOver-the-counter consumer health products sold via e-commerce

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Actor Pharmaceuticals Pty Ltd product offering

Product offering

Core offering

Actor Pharmaceuticals Pty Ltd distributes and markets a portfolio of prescription specialty pharmaceuticals and biosimilar medicines alongside a 12-brand range of over-the-counter consumer health products covering anxiety/mood, antifungal, cough/cold, digestive, pain management, skincare, sleep, and women's wellness. The company serves Australian consumers directly through its Shopify-based e-commerce platform and Australian pharmacies, with select brands (e.g., Prospan) also distributed in New Zealand via local partners.

Product overview

Actor Pharmaceuticals Pty Ltd is an Australian specialty pharmaceutical company offering a dual portfolio of Consumer Health (OTC) products and Prescription Medicines. The Consumer Health portfolio includes 12 over-the-counter brands covering therapeutic categories including Sinupret® (sinusitis), Premular®/Femular®/Redormin®/Remotiv® (women's wellness and sleep/anxiety), Kenkay®/DermaScar® (skincare), Zostrix® (pain relief), Prospan® (cough), Excilor (antifungal), Canephron® (urinary health), and Prunelax® (digestive). The Prescription Medicines division provides specialist treatments including ACTOBET® and WYNZORA® (dermatology, calcipotriol/betamethasone), ANDRIGA-10® (urology/oncology), AXHIDROX® (hyperhidrosis), and KLISYRI® (actinic keratosis). The company also distributes biosimilar medicines to the Australian healthcare industry.

Differentiator

Problem solved

Functional benefit

Brands

  • Prospan: Scientifically researched to relieve chesty cough, clear the airways and soothe the throat
  • DermaScar
  • Prunelax
  • Excilor
  • Sinupret
  • Zostrix
  • Kenkay
  • Premular
  • Femular
  • Redormin
  • Remotiv
  • Canephron

Products and services

  • Prospan

Companies that use Actor Pharmaceuticals Pty Ltd

Customer profile

Segments2 records

Ideal customer profiles2 records

Actor Pharmaceuticals Pty Ltd technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Actor Pharmaceuticals Pty Ltd partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Almirall, S.A.coreOEM/ Whitelabel/ Licensing PartnerKlisyri (tirbanibulin ointment) is a registered trademark under license by Almirall, S.A., indicating a licensing arrangement where Actor Pharmaceuticals distributes this product in Australia.
  • Dr. August Wolff GmbH & Co. KG ArzneimittelcoreOEM/ Whitelabel/ Licensing PartnerAxhidrox (glycopyrronium bromide cream) is a registered trademark of Dr. August Wolff GmbH & Co. KG Arzneimittel, licensed to Actor Pharmaceuticals for distribution.
  • MC2 Therapeutics Pty LtdcoreOEM/ Whitelabel/ Licensing PartnerWYNZORA (calcipotriol and betamethasone cream) is a registered trademark of MC2 Therapeutics Pty Ltd with PAD Technology trademark, licensed to Actor Pharmaceuticals for Australian distribution.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Actor Pharmaceuticals Pty Ltd competitors and assessment

Company assessment

Direct peers

  • Ego Pharmaceuticals: Privately held Australian specialty pharmaceutical and OTC consumer health company, with a comparable portfolio of dermatology (QV skincare) and prescription products marketed through Australian pharmacies — directly comparable in business model and target market.
  • Generic Health: Australian specialty and generic pharmaceutical company supplying PBS-listed medicines through pharmacy channels — direct comparable for Actor's prescription distribution and PBS strategy.
  • iNova Pharmaceuticals: Australia/NZ-focused specialty pharma company selling prescription medicines and OTC consumer health brands through pharmacy and healthcare professional channels, closely mirroring Actor's Rx + OTC dual model.
  • AFT Pharmaceuticals: ASX- and NZX-listed specialty pharma company commercialising patented and in-licensed prescription and OTC products across Australia and New Zealand, comparable in geographic focus and licensing-driven model.

Broad incumbents

  • Mayne Pharma Group: ASX-listed Australian specialty pharmaceutical company focused on branded Rx and dermatology products, providing a scaled publicly-listed comparison for Actor's specialty prescription portfolio.
  • Mundipharma: Specialty pharmaceutical group with deep Australian and Asia-Pacific presence in pain, oncology and consumer health — competing with Actor's prescription pain (Zostrix-equivalents) and OTC categories.
  • Bayer Australia Consumer Health: Multinational consumer health division with established Australian OTC portfolio across cough/cold, pain and dermatology — directly relevant peer for Actor's consumer health categories.
  • Sanofi Consumer Healthcare Australia: Multinational pharmaceutical company with a sizeable Australian consumer health and specialty Rx franchise, similar multi-channel mix at materially greater scale.
  • Aspen Pharmacare Australia: Australian arm of a global specialty and generic pharma group marketing a broad branded Rx and OTC portfolio through local distribution — overlaps with Actor's portfolio breadth but at far greater scale.
  • Blackmores: Leading Australian OTC consumer health brand company, competing head-on with Actor's OTC supplements for women's wellness, sleep and anxiety (e.g. Remotiv, Redormin).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Actor Pharmaceuticals Pty Ltd social profiles

Digital presence

Actor Pharmaceuticals Pty Ltd financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Actor Pharmaceuticals Pty Ltd leadership team

Management profile

Number of profiles

Actor Pharmaceuticals Pty Ltd funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Actor Pharmaceuticals Pty Ltd M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Actor Pharmaceuticals Pty Ltd

What does Actor Pharmaceuticals Pty Ltd do?

Actor Pharmaceuticals Pty Ltd distributes and markets a portfolio of prescription specialty pharmaceuticals and biosimilar medicines alongside a 12-brand range of over-the-counter consumer health products covering anxiety/mood, antifungal, cough/cold, digestive, pain management, skincare, sleep, and women's wellness. The company serves Australian consumers directly through its Shopify-based e-commerce platform and Australian pharmacies, with select brands (e.g., Prospan) also distributed in New Zealand via local partners.

Is Actor Pharmaceuticals Pty Ltd a public or private company?

Actor Pharmaceuticals Pty Ltd is a private company. It is classified as unknown and is currently operating.

When was Actor Pharmaceuticals Pty Ltd founded?

Actor Pharmaceuticals Pty Ltd was founded in -1. It employs 11 to 50 people.

Where is Actor Pharmaceuticals Pty Ltd based?

Actor Pharmaceuticals Pty Ltd is headquartered in Sydney, Australia, in the Oceania region.

How does Actor Pharmaceuticals Pty Ltd make money?

Three revenue lines are on record. Prescription Pharmaceuticals are the primary driver. The others are over-the-Counter (OTC) Consumer Health Products and licensing Royalties.

Who are Actor Pharmaceuticals Pty Ltd's main competitors?

Direct peers on record are Ego Pharmaceuticals, Generic Health, iNova Pharmaceuticals and AFT Pharmaceuticals. Broad incumbents are Mayne Pharma Group, Mundipharma, Bayer Australia Consumer Health, Sanofi Consumer Healthcare Australia, Aspen Pharmacare Australia and Blackmores.

Does Actor Pharmaceuticals Pty Ltd have an API?

No public API is recorded for Actor Pharmaceuticals Pty Ltd.

What industry is Actor Pharmaceuticals Pty Ltd in?

Actor Pharmaceuticals Pty Ltd's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 456 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales